ArticleCancer immunology, immunotherapy : CII2023

Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis.

Jiashuo Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.